These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glucocorticoids in the medical management of Graves' ophthalmopathy. Hart RH; Perros P Minerva Endocrinol; 2003 Sep; 28(3):223-31. PubMed ID: 14605604 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of Basedow's exophthalmos]. Ben Abdallah N; Ennouri A; Ben Ayed H Tunis Med; 1990; 68(6-7):407-10. PubMed ID: 2238135 [No Abstract] [Full Text] [Related]
4. [Internal (medical) and surgical treatment of endocrine exophthalmos]. Boerema I; Stortenbeek W Ned Tijdschr Geneeskd; 1970 Feb; 114(9):361-8. PubMed ID: 5467077 [No Abstract] [Full Text] [Related]
5. [The medical treatment of endocrine exophthalmos]. Glinoer D Bull Soc Belge Ophtalmol; 1988; 226():59-64. PubMed ID: 3268307 [No Abstract] [Full Text] [Related]
6. [Medical treatment of endocrine exophthalmos]. Lavergne G; Winand R Ann Ocul (Paris); 1970 May; 203(5):469-72. PubMed ID: 4193819 [No Abstract] [Full Text] [Related]
7. Immunosuppressive therapy for the eye changes of Graves' disease. Burrow GN; Mitchell MS; Howard RO; Morrow LB J Clin Endocrinol Metab; 1970 Sep; 31(3):307-11. PubMed ID: 4916539 [No Abstract] [Full Text] [Related]
8. [Treatment of severe endocrine ophthalmopathy with cyclosporin A]. Bakó G; Fórizs E; Herczeg L; Kolozsvári L; Leövey A Orv Hetil; 1987 Aug; 128(35):1843-4. PubMed ID: 3627788 [No Abstract] [Full Text] [Related]
9. [On the anti-exophthalmic and anti-thyroid action of an imidazole derivative with trichomonacidal action: metronidazole]. Portioli I; Rocchi F; Maraini G; Pescatori A Ann Ottalmol Clin Ocul; 1968 Dec; 94(12):1457-73. PubMed ID: 5757142 [No Abstract] [Full Text] [Related]
10. Methylprednisolone in the treatment of exophthalmos. Garber MI Lancet; 1966 Apr; 1(7444):958-60. PubMed ID: 4160651 [No Abstract] [Full Text] [Related]
12. [Is treatment with corticotherapy or radiotherapy effective for involvement of ocular motility and for reduction of exophthalmos in Basedow's disease?]. Waterschoot MP; Cordonnier M; Van Nechel C; Vanheesbeke A; Zanen A Bull Soc Belge Ophtalmol; 1994; 254():93-105. PubMed ID: 7493132 [TBL] [Abstract][Full Text] [Related]
13. [The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus]. Depisch D; Höfer R; Schatz H Wien Klin Wochenschr; 1969 Jan; 81(1):8-10. PubMed ID: 5818436 [No Abstract] [Full Text] [Related]
15. Methylprednisolone and Graves' ophthalmopathy. Dandona P; Havard CW; Mier A BMJ; 1989 Mar; 298(6676):830. PubMed ID: 2496877 [No Abstract] [Full Text] [Related]
16. [Treatment of malignant exophthalmos with beta-1-24 corticotropin]. Kolebinov N; Popov NG; Razsolkov M Vutr Boles; 1973; 12(3):80-5. PubMed ID: 4356592 [No Abstract] [Full Text] [Related]
17. [Remission of edematous exophthalmos during chlorambucil treatment]. Sebaoun J; Delzant G; Peillon F; Schaison M; Gilbert-Dreyfus Ann Endocrinol (Paris); 1967; 28(3):362-7. PubMed ID: 6080194 [No Abstract] [Full Text] [Related]
18. [Acute erythroleukemia following treatment of malignant exophthalmos with chlorambucil]. Laroche C; Caquet R; Remy JM Nouv Presse Med; 1972 Dec; 1(46):3133. PubMed ID: 4510064 [No Abstract] [Full Text] [Related]
19. Management of the active severe eye changes of Graves' disease. Werner SC Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401 [No Abstract] [Full Text] [Related]